Regular market approval to Covishield, Covaxin expected soon after final price fixation: Sources

Jan 26, 2022

New Delhi [India], January 26 : The regular market approval from Drugs Controller General of India (DCGI) to COVID-19 vaccine Covishield and Covaxin is...

DCGI grants conditional market approval for Covaxin, Covishield

Jan 27, 2022

New Delhi [India], January 27 : The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin...

SEC recommends India's first indigenously developed vaccine against cervical cancer for 9 to 26-year age group

Jun 15, 2022

New Delhi [India], June 15 : The subject expert committee meeting that was scheduled today to discuss Serum Institute of India's (SII) indigenously developed...

SEC recommends regular market approval to Covaxin, Covishield for adults

Jan 19, 2022

New Delhi [India], January 19 : The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to...

COVID-19 vaccine maybe available in open market by year end: AIIMS Director

Feb 17, 2021

New Delhi [India], February 17 : Coronavirus vaccines might be available in the open market by end of the year only when prime targeted...

Global disparity in access to essential vaccines in demand by wealthy nations: WHO

Nov 10, 2022

Approximately 16 billion vaccine doses, worth USD 141 billion, were supplied in 2021, almost three times the 2019 market volume (5.8 billion) and nearly...